On Friday, AbCellera Biologics Inc (NASDAQ: ABCL) opened lower -13.69% from the last session, before settling in for the closing price of $4.53. Price fluctuations for ABCL have ranged from $1.89 to $6.51 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -107.74% over the past five years. Company’s average yearly earnings per share was noted -7.27% at the time writing. With a float of $225.81 million, this company’s outstanding shares have now reached $299.01 million.
AbCellera Biologics Inc (ABCL) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of AbCellera Biologics Inc is 24.56%, while institutional ownership is 35.75%.
AbCellera Biologics Inc (ABCL) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.12 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.15) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.11% during the next five years compared to -107.74% drop over the previous five years of trading.
AbCellera Biologics Inc (NASDAQ: ABCL) Trading Performance Indicators
Check out the current performance indicators for AbCellera Biologics Inc (ABCL). In the past quarter, the stock posted a quick ratio of 10.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 33.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.58, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.50 in one year’s time.
Technical Analysis of AbCellera Biologics Inc (ABCL)
AbCellera Biologics Inc (NASDAQ: ABCL) saw its 5-day average volume 6.79 million, a positive change from its year-to-date volume of 5.1 million. As of the previous 9 days, the stock’s Stochastic %D was 11.13%.
During the past 100 days, AbCellera Biologics Inc’s (ABCL) raw stochastic average was set at 23.72%, which indicates a significant increase from 19.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.32 in the past 14 days, which was lower than the 0.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.09, while its 200-day Moving Average is $3.60. Nevertheless, the first resistance level for the watch stands at $4.14 in the near term. At $4.37, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.73. If the price goes on to break the first support level at $3.55, it is likely to go to the next support level at $3.19. Assuming the price breaks the second support level, the third support level stands at $2.96.
AbCellera Biologics Inc (NASDAQ: ABCL) Key Stats
There are currently 298,833K shares outstanding in the company with a market cap of 1.17 billion. Presently, the company’s annual sales total 28,830 K according to its annual income of -162,860 K. Last quarter, the company’s sales amounted to 17,080 K and its income totaled -34,730 K.
